Antengene Investor Presentation November 2023

Antengene Corporation Limited presents corporate overview and strategic initiatives. The presentation covers investigational drug candidates, clinical trial progress, development and commercialization efforts. Focus on treating patients beyond borders with pharmaceutical innovation.